AEterna Zentaris Inc. (USA) (AEZS) Is Down, But Probably Not Out
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) is taking a major hit premarket, having put out data from its lead trial after hours on Wednesday. The data relates to a drug called Macrilen (macimorelin), and the company was investigating it as a potential evaluation therapy (basically, a diagnostic) for growth hormone deficiency in adults (AGHD). As yet, […]